alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<PAGE>

                                                                   EXHIBIT 10.36

                        PINNACLE FINANCIAL PARTNERS, INC.
                  NAMED EXECUTIVE OFFICER COMPENSATION SUMMARY

The following table sets forth the current base salaries paid to the Chief
Executive Officer and the four other named executive officers of Pinnacle
Financial Partners, Inc. (the "Company") and the amount of the cash bonus paid
to these persons in 2006 under the Company's 2005 Cash Incentive Plan.

<TABLE>
<CAPTION>
   Executive Officer                                    Current Salary          2005 Cash Bonus
   -----------------                                    --------------          ---------------
<S>                                                     <C>                     <C>
M. Terry Turner - CEO                                      $ 330,000                $165,000
Robert A. McCabe, Jr. - Chairman of the Board              $ 313,500                $156,750
Hugh M. Queener - CAO                                      $ 217,000                $ 86,800
Harold R. Carpenter - CFO                                  $ 157,000                $ 62,800
Charles B. McMahan - Sr. Credit Officer                    $ 154,336                $ 46,300
</TABLE>

In addition to their base salaries, these executive officers are also eligible
to:

      -     Receive cash bonuses under the Company's 2006 Cash Incentive Plan;

      -     Participate in the Company's equity incentive programs, which
            currently involves the award of non-qualified stock options and
            restricted stock pursuant to the Company's 2004 Equity Incentive
            Plan; and

      -     Participate in the Company's broad-based benefit programs generally
            available to its employees, including health, disability and life
            insurance programs and the Company's 401k plan.

Additionally, Messrs. Turner, McCabe and Queener receive a monthly car
allowance.

The foregoing information is summary in nature. Additional information regarding
the named executive officer compensation will be provided in the Company's proxy
statement to be filed in connection with the 2006 annual meeting of the
Company's shareholders.
<PAGE>
                                                                      EXHIBIT 21



                                ENERGYSOUTH, INC.


                           SUBSIDIARIES OF REGISTRANT



<Table>
<Caption>
                                                         Percent of Voting                       State of
           Subsidiary                                    Securities Owned                      Incorporation
--------------------------------                         -----------------                     -------------
<S>                                                      <C>                                   <C>
Mobile Gas Service Corporation                                 100%                              Alabama

MGS Storage Services, Inc.                                     100%                              Alabama

EnergySouth Services, Inc.                                     100%                              Alabama

MGS Marketing Services, Inc.                                   100%                              Alabama
</Table>


                PARTNERSHIPS IN WHICH REGISTRANT OWNS AN INTEREST

<Table>
<Caption>
         Partnership                                    Equity Ownership
-----------------------------                           -----------------
<S>                                                     <C>
Bay Gas Storage Company, Ltd.                                 90.9%

Southern Gas Transmission Co.                                  51%
</Table>
II 

113TH CONGRESS 

1ST SESSION H. R. 2922 

IN THE SENATE OF THE UNITED STATES 

NOVEMBER 13, 2013 

Received 

AN ACT 

To extend the authority of the Supreme Court Police to 

protect court officials away from the Supreme Court grounds. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 


pwalker on DSK7TPTVN1PROD with BILLS
2 

HR 2922 RDS

1 SECTION 1. EXTENSION OF AUTHORITY OF SUPREME 

2 COURT POLICE TO PROTECT COURT OFFI3 CIALS OFF SUPREME COURT GROUNDS. 

4 Section 6121(b)(2) of title 40, United States Code, 

5 is amended by striking ‘‘2013’’ and inserting ‘‘2019’’. 

Passed the House of Representatives November 12, 

2013. 

Attest: KAREN L. HAAS, 

Clerk. 


pwalker on DSK7TPTVN1PROD with BILLS
[Federal Register Volume 65, Number 201 (Tuesday, October 17, 2000)]
[Notices]
[Pages 61347-61348]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-26580]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Child Health and Human Development; Notice 
of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Child Health and Human 
Development Initial Review Group, Mental Retardation Research 
Subcommittee, Mental Retardation Research Subcommittee.
    Date: October 19-20, 2000.
    Time: 7:30 am to 5 pm.
    Agenda: To review and evaluate grant applications.
    Place: Georgetown Suites, 1000 29th Street, N.W., Washington, DC 
20007.
    Contact Person: Norman Chang, PhD, Scientific Review 
Administrator, National Institute of Child Health and Human 
Development, National Institutes of Health, PHS, DHHS, Bethesda, MD 
20892.
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.209, 
Contraception and Infertility Loan Repayment Program; 93.864, 
Population Research; 93.865, Research for Mothers and Children; 
93.929, Center for Medical Rehabilitation Research, National 
Institutes of Health, HHS)


[[Page 61348]]


    Dated: October 6, 2000.
Anna P. Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 00-26580 Filed 10-16-00; 8:45 am]
BILLING CODE 4140-01-M
**Exhibit 31.2**

**CERTIFICATIONS**

I, Stephen E. Tremblay, certify that:

1.             Ihave reviewed this annual report on Form 10-K of Vertis, Inc.;

2.             Basedon my knowledge, this report does not contain any untrue statement of amaterial fact or omit to state a material fact necessary to make the statementsmade, in light of the circumstances under which such statements were made, notmisleading with respect to the period covered by this report;

3.             Basedon my knowledge, the financial statements, and other financial informationincluded in this report, fairly present in all material respects the financialcondition, results of operations and cash flows of the registrant as of, andfor, the periods presented in this report;

4.             Theregistrant’s other certifying officer(s) and I are responsible forestablishing and maintaining disclosure controls and procedures (as defined inExchange Act Rules 13a-15(e) and 15d-15(e)) for theregistrant and have:

(a)          Designed such disclosure controls and procedures, or causedsuch disclosure controls and procedures to be designed under our supervision,to ensure that material information relating to the registrant, including itsconsolidated subsidiaries, is made known to us by others within those entities,particularly during the period in which this report is being prepared;

(c)          Evaluated the effectiveness of the registrant’s disclosurecontrols and procedures and presented in this report our conclusions about theeffectiveness of the disclosure controls and procedures, as of the end of the periodcovered by this report based on such evaluation; and

(d)          Disclosed in this report any change in the registrant’sinternal control over financial reporting that occurred during the registrant’smost recent fiscal quarter (the registrant’s fourth fiscal quarter in the caseof an annual report) that has materially affected, or is reasonably likely tomaterially affect, the registrant’s internal control over financial reporting;and

5.             Theregistrant’s other certifying officer(s) and I have disclosed, based onour most recent evaluation of internal control over financial reporting, to theregistrant’s auditors and the audit committee of registrant’s board ofdirectors (or persons performing the equivalent functions):

(a)          All significant deficiencies and material weaknesses in thedesign or operation of internal control over financial reporting which arereasonably likely to adversely affect the registrant’s ability to record,process, summarize and report financial information; and

(b)          Anyfraud, whether or not material, that involves management or other employees whohave a significant role in the registrant’s internal control over financialreporting.

|   |       | /s/ STEPHEN E.  TREMBLAY            |
|--------|------------|-------------------------------------|
|   | ** ** | **Name: Stephen E. Tremblay**  |
|   |       | Title: Chief Financial Officer |

 

**Date: April 2, 2007**

----
IN THE UNITED STATES DISTRICT COURT

FOR THE WESTERN DISTRICT OF TEXAS

WACO DIVISION

WSOU INVESTMENTS, LLC d/b/a BRAZOS 

LICENSING AND DEVELOPMENT,

Plaintiff,

v.

DELL TECHNOLOGIES INC., DELL INC., 

AND EMC CORPORATION,

Defendants.

Case No. 6:20-cv-00475-ADA

JURY TRIAL DEMANDED

DECLARATION OF BRIAN A. ROSENTHAL IN SUPPORT OF DEFENDANTS’ 

SECOND NOTICE OF SUPPLEMENTAL EVIDENCE IN SUPPORT OF OPPOSED 

MOTION FOR INTRA-DISTRICT TRANSFER OF VENUE 

TO THE AUSTIN DIVISION OF THE WESTERN DISTRICT OF TEXAS

Case 6:20-cv-00475-ADA Document 110-1 Filed 08/20/21 Page 1 of 3
1

I, Brian A. Rosenthal, declare as follows:

1. I am an attorney permitted to practice law before this Court pro hac vice and am 

licensed to practice law in New York and the District of Columbia. I am a partner with the law 

firm of Gibson, Dunn & Crutcher LLP and counsel of record for Defendants Dell Technologies 

Inc., Dell Inc., and EMC Corporation in the above-captioned action. I have personal knowledge 

and/or am directly informed of the matters stated below and, if called, would testify to them under 

oath.

2. Attached hereto as Exhibit 28 is a true and correct copy of WSOU Investments, 

LLC d/b/a Brazos Licensing and Development’s Rule 26(a) Initial Disclosures, which was served 

in Cases Nos. 6:20-cv-473; 6:20-cv-474; 6:20-cv-475; 6:20-cv-476; 6:20-cv-479; 6:20-cv-480; 

6:20-cv-481; 6:20-cv-482; 6:20-cv-485; and 6:20-cv-486, on April 29, 2021.

3. Attached hereto as Exhibit 29 is a true and correct copy of a Patent Security 

Agreement, dated May 28, 2021, and obtained from the United States Patent and Trademark 

Office’s website at https://assignment.uspto.gov/patent/index.html, on August 19, 2021.

4. Attached hereto as Exhibit 30 is a true and correct copy of a Power of Attorney, 

dated August 13, 2021, and obtained from the United States Patent and Trademark Office’s 

website at https://portal.uspto.gov/pair/PublicPair, on August 19, 2021.

5. Attached hereto as Exhibit 31 is a true and correct copy of a June 1, 2021 hearing 

transcript from WSOU Investments LLC v. Juniper Networks, Inc., Case No. 20-cv-903 (W.D. 

Tex.), that was filed in Case No. 21-160 (Fed. Cir.), and obtained on August 19, 2021.

6. Attached hereto as Exhibit 32 is a true and correct copy of Powers of Attorney, 

obtained from the United States Patent and Trademark Office’s website at https://ptab.uspto.gov/, 

on August 19, 2021.

Case 6:20-cv-00475-ADA Document 110-1 Filed 08/20/21 Page 2 of 3
2

I declare under penalty of perjury that the foregoing is true and correct.

Dated: August 20, 2021

/s/ Brian A. Rosenthal Brian A. Rosenthal

Case 6:20-cv-00475-ADA Document 110-1 Filed 08/20/21 Page 3 of 3
Exhibit 32







CERTIFICATION PURSUANT TO 18 U.S.C SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



In connection with the Report of Strateco Resources Inc. (the Company) on Form 10K-SB/A for the period ending December 31, 2003, which contains the Companys financial statements for the years ended December 31, 2003 and 2002, as filed with the Securities and Exchange Commission on the date hereof (the Report), I Guy Hébert, President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that:



(1)

the Report fully complies with the requirements of section 13(a) of 15(d) of the Securities Exchange Act of 1934;



and



(2)

the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



Dated :  May, 12, 2004



/s/ Guy Hébert

__________________

Guy Hébert

President and Chief Executive Officer
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. 

*Name of Committee:*                        National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel, ZDK1 GRB 4J1.                    

*Date:*                        November 29-30, 2000.                    

*Time:*                        7 p.m. to 7 p.m.                    

*Agenda:*                        To review and evaluate grant applications.                    

*Place:*                        The San Luis Resort and Conference Center, 5222 Seawall Boulevard, Galveston, TX 77551.                    

*Contact Person:*                        William E. Elzinga, Scientific Review Administrator, Review Branch, DEA NIDDK, Room 647, 6707 Democracy Boulevard, National Institutes of Health, Bethesda, MD 20892-6600; (301) 594-8895.                     

(Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS)

Dated: October 13, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory Committee Policy.

[FR Doc. 00-26960 Filed 10-19-00; 8:45 am]

BILLING CODE 4140-01-M
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONSOLIDATED SUMMARY BALANCE SHEETS AS OF FEBRUARY 10, 1996 AND THE
CONSOLIDATED SUMMARY STATEMENTS OF INCOME FOR THE 24 WEEKS ENDED
FEBRUARY 10, 1996 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          AUG-31-1996
<PERIOD-END>                               FEB-10-1996
<CASH>                                           8,702
<SECURITIES>                                         0
<RECEIVABLES>                                   76,706
<ALLOWANCES>                                    10,552
<INVENTORY>                                     80,225
<CURRENT-ASSETS>                               179,290
<PP&E>                                         128,964
<DEPRECIATION>                                  68,459
<TOTAL-ASSETS>                                 278,609
<CURRENT-LIABILITIES>                           76,113
<BONDS>                                         60,086
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        10,997
<OTHER-SE>                                     130,144
<TOTAL-LIABILITY-AND-EQUITY>                   278,609
<SALES>                                        553,249
<TOTAL-REVENUES>                               555,604
<CGS>                                          527,972
<TOTAL-COSTS>                                  527,972
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                 1,545
<INTEREST-EXPENSE>                               3,243
<INCOME-PRETAX>                                  8,104
<INCOME-TAX>                                     3,110
<INCOME-CONTINUING>                              4,994
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     4,994
<EPS-PRIMARY>                                      .46
<EPS-DILUTED>                                      .46
        

</TABLE>
Exhibit
32.1


WESTERN
RESERVE BANCORP, INC.


FORM
10-K


Year
ended December 31, 2009





CERTIFICATION
PURSUANT TO


18
U.S.C. SECTION 1350,


AS
ENACTED PURSUANT TO


SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002





In
connection with the Annual Report of Western Reserve Bancorp, Inc. (the
"Company") on Form 10-K for the period ending December 31, 2009 as filed with
the Securities and Exchange Commission on the date hereof (the "Report"), I,
Edward J. McKeon, Chief Executive Officer of the Company, certify, pursuant to
18 U.S.C. § 1350, as enacted pursuant to Section 906 of the Sarbanes-Oxley Act
of 2002, that:





(1)  The
Report fully complies with the requirements of section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and





(2)  The
information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the Company.





/s/ Edward J. McKeonEdward
      J. McKeonPresident
      and Chief Executive OfficerMarch
      23, 2010
Exhibit 10.2


 


FIRST
AMENDMENT TO

CASCADE NATURAL GAS CORPORATION

2000 DIRECTOR STOCK AWARD PLAN


This
First Amendment to the 2000 Director Stock Award Plan (“First Amendment”) is
dated February 17, 2006, and amends that certain 2000 Director Stock Award
Plan (the “Plan”) of Cascade Natural Gas Corporation (the “Corporation”).
Capitalized terms not otherwise defined in this First Amendment shall have the
meanings set forth in the Plan.


AMENDMENTS


Pursuant
to its authority under Section 9.2 of the Plan, the Board of Directors of
the Corporation hereby amends the Plan as follows:


1.      Grant of Stock Awards.   Section 6.1
of the Plan is amended in its entirety to read as follows:


“6.1   Grant
of Stock Awards.   As of each April 24 in 2000 and
subsequent years, Cascade automatically shall grant to each person who served
as a Director during the period since the preceding April 24 a Stock
Award. The Stock Award to be granted in the years 2000 - 2005 shall be 500
Shares. The Stock Award to be granted in 2006 and subsequent years shall be
1,000 Shares. The number of Shares granted each year shall be subject to any
adjustment required or permitted pursuant to Article 8. Each such grant
shall occur automatically during the term of this Plan without further action
of the Board.”


2.      Approvals.   This
First Amendment was duly approved by the Board of Directors of the Corporation
on November 14, 2005, and was approved by the Shareholders of the
Corporation on February 17, 2006.


3.      Other Provisions.   Except as expressly
amended by this First Amendment, the Plan shall remain in full force and
effect.
```

[Congressional Bills 112th Congress]
[From the U.S. Government Publishing Office]
[H.R. 5571 Introduced in House (IH)]

112th CONGRESS
  2d Session
                                H. R. 5571

       To extend the temporary suspension of duty on 2-methyl-5-
                       nitrobenzenesulfonic acid.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                              May 8, 2012

   Mr. Clay introduced the following bill; which was referred to the 
                      Committee on Ways and Means

_______________________________________________________________________

                                 A BILL

 
       To extend the temporary suspension of duty on 2-methyl-5-
                       nitrobenzenesulfonic acid.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. 2-METHYL-5-NITROBENZENESULFONIC ACID.

    (a) In General.--Heading 9902.29.23 of the Harmonized Tariff 
Schedule of the United States (relating to 2-methyl-5-
nitrobenzenesulfonic acid) is amended by striking the date in the 
effective period column and inserting ``12/31/2015''.
    (b) Effective Date.--The amendment made by subsection (a) applies 
with respect to goods entered, or withdrawn from warehouse for 
consumption, on or after the 15th day after the date of the enactment 
of this Act.
                                 <all>
```
Exhibit 99.1

CERTIFICATION PURSUANT TO  18 U.S.C. SECTION 1350,  AS ADOPTED PURSUANT TO  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Stone Container Corporation (the "Company") on Form 10-Q for the period ending March 31, 2003 as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), I, Patrick J. Moore, President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as
adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:



|/s/PATRICK J. MOOREPatrick J. Moore President
and Chief Executive OfficerMay 7, 2003 |  | 
|------------------------------------------------------------------------------------ |  | 

A
signed original of this written statement required by Section 906 has been provided to Stone Container Corporation and will be retained by Stone Container Corporation and furnished to
the Securities and Exchange Commission or its staff upon request.

---

QuickLinks